Search - tctmd.com

Displaying 421 - 440 of 1176

Sort: Relevancy | Date

News Daily News

Evolut Valves: Initial Positioning Can Be Optimized for Future Coronary Access

Michael O'Riordan

July 10, 2019

News Daily News

Life Expectancy Post-SAVR Varies by Age, Raising Questions for Treatment Timing

Caitlin E. Cox

July 01, 2019

News Daily News

High Levels of Lp(a) Linked to Increased Ischemic Stroke Risk

Michael O'Riordan

July 01, 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for June 2019

Shelley Wood

June 28, 2019

News Daily News

New TAVR NCD a ‘Missed Opportunity’ to Align SAVR, TAVR Quality

Shelley Wood

June 27, 2019

News Daily News

Genetic Data Hint at Causal Link Between High BMI and Cardiovascular Diseases

Marcus A. Banks

June 24, 2019

News Conference News TVT 2019

Better Hemodynamics, Less Mismatch With Self-Expanding TAVR vs Surgery

Michael O'Riordan

June 20, 2019

News Conference News TVT 2019

Faster and Larger Gains in Physical Function With TAVR Than With Surgery: SURTAVI

Michael O'Riordan

June 17, 2019

News Daily News

TCAR Use Growing for Carotid Stenosis as Positive Data Continue to Accumulate

Todd Neale

June 17, 2019

News Conference News TVT 2019

Vast Numbers of Severe Symptomatic AS Patients Untreated? A Plea and Some Pushback

Shelley Wood

June 14, 2019

News Conference News TVT 2019

Real-world Stroke With TAVR: TVT Registry Insights Rekindle Cerebral Protection Debate

Shelley Wood

June 13, 2019

News Conference News TVT 2019

PCI During or After TAVR No Riskier Than PCI Before Valve Replacement

Michael O'Riordan

June 13, 2019

News Daily News

TAVR Growing in the US, but Vast Majority of Patients Not Receiving Any Form of Valve Replacement

Michael O'Riordan

June 12, 2019

News Daily News

TAVR in End-stage Renal Disease: Increased Risk Highlights Research Gaps

Yael L. Maxwell

June 11, 2019

News Daily News

Similar Mortality, Higher Early Stroke Risks in TAVR for Bicuspid Aortic Stenosis

Michael O'Riordan

June 11, 2019

News Conference News EAS 2019

Should Lp(a) Be Measured and Treated? Two Experts Hash Out Its Current Role

Michael O'Riordan

June 07, 2019

News Conference News SCAI 2019

TAVR Operators: Can One Do It All or Are Two Still Justified?

Yael L. Maxwell

June 04, 2019

News Conference News EuroPCR 2019

Allegra TAVR System Feasible for Treating Degenerated Surgical Valves

Michael O'Riordan

May 29, 2019

CHOICE: Better Hemodynamics, Less Structural Deterioration with CoreValve

News Conference News EuroPCR 2019

Self-Expanding vs Balloon-Expandable TAVR? Some Insights From CHOICE

Michael O'Riordan

May 24, 2019

News Conference News EuroPCR 2019

TAVR Durability ‘Snapshot’ Offers Some Reassurances 8 to 10 Years Out

Caitlin E. Cox

May 24, 2019

Advertisement

Evolut Valves: Initial Positioning Can Be Optimized for Future Coronary Access

Life Expectancy Post-SAVR Varies by Age, Raising Questions for Treatment Timing

High Levels of Lp(a) Linked to Increased Ischemic Stroke Risk

TCTMD’s Top 10 Most Popular Stories for June 2019

New TAVR NCD a ‘Missed Opportunity’ to Align SAVR, TAVR Quality

Genetic Data Hint at Causal Link Between High BMI and Cardiovascular Diseases

Better Hemodynamics, Less Mismatch With Self-Expanding TAVR vs Surgery

Faster and Larger Gains in Physical Function With TAVR Than With Surgery: SURTAVI

TCAR Use Growing for Carotid Stenosis as Positive Data Continue to Accumulate

Vast Numbers of Severe Symptomatic AS Patients Untreated? A Plea and Some Pushback

Real-world Stroke With TAVR: TVT Registry Insights Rekindle Cerebral Protection Debate

PCI During or After TAVR No Riskier Than PCI Before Valve Replacement

TAVR Growing in the US, but Vast Majority of Patients Not Receiving Any Form of Valve Replacement

TAVR in End-stage Renal Disease: Increased Risk Highlights Research Gaps

Similar Mortality, Higher Early Stroke Risks in TAVR for Bicuspid Aortic Stenosis

Should Lp(a) Be Measured and Treated? Two Experts Hash Out Its Current Role

TAVR Operators: Can One Do It All or Are Two Still Justified?

Allegra TAVR System Feasible for Treating Degenerated Surgical Valves

Self-Expanding vs Balloon-Expandable TAVR? Some Insights From CHOICE

TAVR Durability ‘Snapshot’ Offers Some Reassurances 8 to 10 Years Out

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content